Loading…
Niva Bupa Health Insurance Company (NIVABUPA)₹75.66−1.84%General Insurance
In the Jun 2026 quarter (standalone), Niva Bupa Health Insurance Company reported revenue of ₹2,467 Cr, up 27.8% from Jun 2025, and net profit of ₹137 Cr, up 94.1% year on year. For the year to Mar 2026, revenue were ₹6,688 Cr and net profit ₹130 Cr.
Company filings, standalone accounts; latest reported quarter Jun 2026
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 968 | 1,025 | 1,316 | 1,123 | 1,321 | 1,257 | 1,669 | 1,931 | 1,572 | 1,610 | 2,249 | 2,467 |
| Expenses | 1,029 | 1,072 | 1,216 | 1,230 | 1,388 | 1,283 | 1,422 | 1,837 | 1,630 | 1,708 | 2,072 | 2,289 |
| Operating Profit | −57.81 | −45.83 | 99.70 | −103 | −65.81 | −23.93 | 250 | 97.72 | −52.80 | −93.64 | 181 | 183 |
| OPM % | −6.0% | −4.4% | 8.0% | −9.0% | −5.0% | −1.9% | 15.0% | 5.0% | −3.4% | −6.0% | 8.0% | 7.0% |
| Other Income | 49.85 | 49.91 | 56.86 | 83.76 | 78.79 | 36.88 | −44.89 | 0.00 | 17.96 | 6.99 | −0.99 | 0.00 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | −8.02 | 5.01 | 157 | −19.03 | 13.02 | 13.03 | 206 | 98.21 | −35.06 | −88.15 | 181 | 184 |
| Tax % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 26.9% | 0.0% | 0.0% | 11.9% | 25.0% |
| Net Profit | −7.97 | 4.98 | 156 | −18.93 | 12.96 | 12.96 | 205 | 70.81 | −34.90 | −87.66 | 158 | 137 |
| EPS (Rs) | — | — | — | — | — | 0.06 | 1.12 | 0.38 | −0.18 | −0.46 | 0.85 | 0.74 |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 850 | 1,056 | 1,413 | 1,876 | 2,851 | 4,115 | 5,369 | 6,688 | 7,899 |
| Expenses | 881 | 1,095 | 1,438 | 2,332 | 3,189 | 4,231 | 5,300 | 6,543 | 7,698 |
| Operating Profit | −28.90 | −36.87 | −21.93 | −450 | −329 | −113 | 82.74 | 160 | 218 |
| OPM % | −3.4% | −3.5% | −1.5% | −24.0% | −12.0% | −2.7% | 1.5% | 2.4% | 2.8% |
| Other Income | 0.00 | 0.00 | 0.00 | 280 | 373 | 223 | 155 | 1.99 | 23.96 |
| Interest | 3.01 | 4.01 | 6.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 16.03 | 21.01 | 22.02 | 27.01 | 32.01 | 29.05 | 25.04 | 36.02 | 0.00 |
| Profit before tax | −48.12 | −62.11 | −50.08 | −197 | 13.02 | 82.12 | 214 | 127 | 242 |
| Tax % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | −3.0% | — |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.99 | 0.99 | 2.99 | 0.00 | 0.00 | — |
| Net Profit | −47.85 | −61.74 | −49.84 | −196 | 12.95 | 81.66 | 213 | 130 | 173 |
| EPS (Rs) | — | — | — | — | — | — | 1.16 | 0.70 | 0.95 |
| Dividend payout % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Equity Capital | 979 | 1,122 | 1,347 | 1,406 | 1,508 | 1,694 | 1,823 | 1,842 |
| Reserves | −720 | −780 | −774 | −904 | −683 | 351 | 1,952 | 1,942 |
| Borrowings | 0.00 | 0.00 | 0.00 | 251 | 250 | 250 | 251 | 251 |
| Other Liabilities | 738 | 891 | 1,321 | 1,978 | 2,792 | 3,875 | 5,711 | 7,219 |
| Total Liabilities | 998 | 1,233 | 1,895 | 2,729 | 3,867 | 6,171 | 9,735 | 11,253 |
| Fixed Assets | 30.03 | 39.08 | 46.06 | 49.09 | 52.10 | 58.07 | 66.11 | 85.21 |
| CWIP | 2.01 | 2.01 | 2.01 | 1.01 | 4.01 | 1.01 | 9.02 | 3.01 |
| Investments | 814 | 1,063 | 1,618 | 2,392 | 3,356 | 5,437 | 8,150 | 9,645 |
| Other Assets | 152 | 129 | 230 | 287 | 455 | 676 | 1,510 | 1,520 |
| Cash & equivalents | 30.08 | 19.07 | 30.09 | 59.18 | 102 | 144 | 221 | 159 |
| Total Assets | 998 | 1,233 | 1,895 | 2,729 | 3,867 | 6,171 | 9,735 | 11,253 |
| Mar 2017 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Cash from operating activity | — | 258 | 339 | 594 | 815 | 1,658 | 907 |
| Cash from investing activity | — | −373 | −720 | −827 | −1,877 | −2,340 | −958 |
| Cash from financing activity | — | 281 | 375 | 281 | 1,113 | 773 | −5.01 |
| Net cash flow | — | 164 | −11.98 | 42.93 | 40.96 | 77.92 | −61.98 |
| Capex | 20.96 | 27.94 | 28.96 | 37.93 | 32.97 | 40.92 | 48.94 |
| Free cash flow | — | 229 | 309 | 555 | 780 | 1,615 | 856 |
| CFO / OP % | — | −1,180.0% | −75.0% | −180.0% | −720.0% | 2,000.0% | 577.0% |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Debtor days | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash conversion cycle | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Working capital days | −264 | −270 | −290 | −341 | −313 | −298 | −351 | −354 |
| ROCE % | — | −19.0% | −9.9% | −30.0% | 1.0% | 5.0% | 7.1% | 3.0% |
For the Jun 2026 quarter, Niva Bupa Health Insurance Company reported revenue of ₹2,467 Cr, up 27.8% year on year and net profit of ₹137 Cr, up 94.1% year on year. The operating margin was 7.0%.
Niva Bupa Health Insurance Company's revenue for the year to Mar 2026 were ₹6,688 Cr; over the last twelve months they were ₹7,899 Cr.
Net profit for the year to Mar 2026 was ₹130 Cr, and ₹173 Cr over the last twelve months. Earnings per share over the same trailing period were ₹0.95.
Niva Bupa Health Insurance Company reported borrowings of ₹251 Cr at Mar 2026, against cash and equivalents of ₹159 Cr.
Cash from operations was ₹907 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹856 Cr.